Bill Details
HR.727 - 119th Congress
Status
Latest action
2025-01-24 - Referred to the House Committee on Energy and Commerce.
Introduced Date
2025-01-24
Policy Area
Health
Committees
View committees (1)
Sponsors
Cosponsors
View cosponsors (12)
- Rep. Weber, Randy K. Sr. [R-Texas-14]
- Rep. Van Duyne, Beth [R-Texas-24]
- Rep. Gosar, Paul A. [R-Arizona-9]
- Rep. Self, Keith [R-Texas-3]
- Rep. Rogers, Harold [R-Kentucky-5]
- Rep. Ellzey, Jake [R-Texas-6]
- Rep. Miller, Mary E. [R-Illinois-15]
- Rep. Babin, Brian [R-Texas-36]
- Rep. Rutherford, John H. [R-Florida-5]
- Rep. Webster, Daniel [R-Florida-11]
- Rep. Moolenaar, John R. [R-Michigan-2]
- Rep. Biggs, Sheri [R-South Carolina-3]
8
0
0
AI Summary This summary was generated by AI from the bill text. AI can get information wrong.
This bill would tighten federal rules on human fetal tissue by broadening what counts as a paid-for exchange. In simple terms, it aims to block sales or other transactions involving human fetal tissue by making the term “valuable consideration” cover not just direct cash payments, but also gifts, forgiven debts, waived fees, free or discounted services, and certain costs tied to handling the tissue. The goal is to close loopholes and make it harder for anyone to treat human fetal tissue as something that can be bought, sold, or traded for value.
- It changes the Public Health Service Act to expand the definition of “valuable consideration” for human fetal tissue transactions.
- The definition would include cash, debt, gifts, honorariums, reduced or waived charges, canceled loans, and free or discounted goods or services.
- It would also cover payments connected to transporting, implanting, processing, preserving, checking quality, or storing human fetal tissue.
- The bill is meant to stop indirect ways of paying for fetal tissue, not just direct sales.
Official Summaries
No summaries available
Current Full Text
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 727 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 727
To amend title IV of the Public Health Service Act to prohibit sale or
transactions relating to human fetal tissue.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 24, 2025
Mr. Scott Franklin of Florida (for himself, Mr. Weber of Texas, Ms. Van
Duyne, Mr. Gosar, Mr. Self, Mr. Rogers of Kentucky, Mr. Ellzey, Mrs.
Miller of Illinois, Mr. Babin, Mr. Rutherford, Mr. Webster of Florida,
and Mr. Moolenaar) introduced the following bill; which was referred to
the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend title IV of the Public Health Service Act to prohibit sale or
transactions relating to human fetal tissue.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Prohibiting Abortion Industry's
Lucrative Loopholes Act''.
SEC. 2. PROHIBITING SALE OR TRANSACTIONS RELATING TO HUMAN FETAL
TISSUE.
Section 498B(e) of the Public Health Service Act (42 U.S.C. 289g-
2(e)) is amended by striking paragraph (3) and inserting the following
new paragraph:
``(3) The term `valuable consideration' includes--
``(A) any payment made or debt incurred;
``(B) any gift, honorarium, or recognition of value
bestowed;
``(C) any price, charge, or fee which is waived,
forgiven, reduced, or indefinitely delayed;
``(D) any loan or debt which is canceled or
otherwise forgiven;
``(E) the transfer of any item from one person to
another or provision of any service or granting of any
opportunity for which a charge is customarily made,
without charge or for a reduced charge; and
``(F) any payments associated with the
transportation, implantation, processing, preservation,
quality control, or storage of human fetal tissue.''.
<all>